Health Archive » October, 2025

Health - October, 2025

404 articles

• Alaska Joins Utah In Firing Motley Rice From Opioid Case
• Drugmakers Can't End States' Dermatology Price-Fixing Suits
• Amgen Again Challenges Colo. Price Cap For Arthritis Drug
• Healthcare Sector Faces Strain Of H-1B Shakeups
• Ga. Panel Says McClain Standard Applies In Sterigenics Case
• Wheeling & Appealing: The Latest Must-Know Appellate Action
• Hawaii Judge Declares FDA's Mifepristone Regs Unlawful
• Up Next At High Court: Tariffs, Fugitives & Contractor Liability
• Opioids Didn't Weigh Heavily In Finances, Hospital Execs Say
• Gov't Owes $330K In Fees For NSF Funding Fight, Court Told
• Minn. Makes More Tribal Deals To Build 'Unique' Pot Market
• FDA Warns Against Fluoride Use In Young Children
• Aetna Strikes $650K Deal In Lipedema Patients' Coverage Suit
• What's New In FDA's Latest Cell And Gene Therapy Guidance
• Drone Co. Says 'Disgruntled' Ex-VP Tried To Torpedo Funding
• Garnet Health Inks $4.6M Deal In Retirement Fee, Fund Suit
• Obesity Drugmaker Escapes Clinical Trial Securities Suit
• 3 Argument Sessions Benefits Attys Should Watch In Nov.
• Ga. Panel Backs Ambulance Co.'s Trial Win In Death Suit
• NC Attorney General, HCA Duel Over Merger Commitments
• Philly Accuses PBMs Of Knowingly Enabling Opioid Crisis
• BetterHelp Wins Defense Costs From Insurer For Privacy Case
• 7th Circ. Won't Revive Antitrust Suit Against Psychiatry Board
• Modivcare's Wind-Down Deal With UnitedHealthcare Gets OK
• Ex-NYU Doc's Disability Bias Verdict Gets Trimmed To $2.55M
• 2nd Ex-Magellan Exec Avoids Jail Over Faulty Lead Tests
• H-1B Fee Guidance Is Helpful But Notable Uncertainty Persists
• J&J's Janssen Says 3rd Circ. Should Reverse $1.6B FCA Win
• Healthcare Nonprofit Hit With Clock-In Pay Suit
• Takeda Fails In Bid To Avoid IBS Drug Antitrust Trial
• Car Auction Co. Ends Medical Marijuana User's Bias Suit
• Risk Mitigation For Psychedelic Use In Reproductive Health
• Tribes Act As Shutdown Threatens Food, Health Services
• Ga. Judge Should DQ Self From Med Mal Case, Couple Say
• Generic-Drug Firms Want To Fast-Track Conn. Price Cap Fight
• Justices' LabCorp Punt Leaves Deeper Class Cert. Circuit Split
• Mich. Top Court Upholds Gilead Immunity In COVID Drug Case
• OpenAI Preps For IPO At $1T Valuation, Plus More Rumors
• Judge Unpauses 'Important' Suit Over Vax Guidelines
• Health Group Urges 1st Circ. To Deny FCA Suit Fee Challenge
• Surgical Co. Gets Tobacco Fee ERISA Suit Kicked To Texas
• Practicing Stoicism Makes Me A Better Lawyer
• Pharmacies Say $1.5B Damages Too Much In Fla. Opioid Suit
• DOJ Subpoena Called 'Pressure' To Ax Gender-Affirming Care
• DexCom Misled Investors About Its Diabetes Tech, Suit Says
• Conn. Med Spa Says Ex-Workers Poaching Clients, Employees
• Shutdown Forces Tribes To Pick Food Or Heat, Senate Told
• Levi & Korsinsky To Lead Modivcare Securities Class Action
• Adapting To Enforcement Focus On Wound Care Fraud
• Pa. Barred From Enforcing Medical Dispensary Staffing Rule
• Healthcare Workers Trade HCA For Subsidiaries In Wage Deal
• FDA Unveils Plan To Speed Biosimilar Drugs To Market
• 3 Pharmaceutical Firms Will Pay $4M To Tribes In Opioid MDL
• Medical Records Fair Game In Juvenile Cases, Pa. Court Rules
• The Biz Court Digest: Texas, One Year In
• AI Product Safety Insights May Expand Foreseeability
• Brothers Found Guilty Of $100M HIV Drug Fraud
• AG Watch: Illinois A Key Player In State-Level Enforcement
• Law School's Missed Lessons: Educating Your Community
• Organ Transplant System Reforms Mark Regulatory Overhaul
• PE-Backed Medical Supplies Giant Medline Files For IPO
• 'Smart Drugs' Amphetamine Suit Moves Forward Minus Execs
• 3 Firms Guide Thermo Fisher On $8.9B Clario Deal
• Fla. Court Reverses $213M Judgment In 'Maya' Case
• CVS, Ad Partner Can't Shake Suit Over User Data Tracking
• Off-Label Prescribing Was Common, Novo Nordisk Tells Jury
• Social Media Apps Say Section 230 Halts Mental Health Claims
• Judge Mulling Hiscox's Arbitration Bid In Legionnaires' Row
• Trump Admin Ordered To Halt Some Shutdown-Linked Layoffs
• Bias Claims From Worker Who Failed Drug Test Can Proceed
• Jushi Sues Doordash, Beverage Sellers Over Hemp Products
• Greenberg Traurig Guides JV's Outpatient Portfolio Buy
• Curaleaf Asks For Quick Action On NJ Pot Shop Union Rule
• Federal Grantees May Soon Face More Limitations On Speech
• Colo. Appellate Panel Backs Order To Donate Pre-Embryos
• Akin Beats Malpractice Claim Over Alleged IP Theft Plot
• HHS Can't Yet Yank Sex Ed Grants Over 'Gender Ideology' Info
• 4th Circ. Overturns Landmark W.Va. Opioid Verdict
• Ga. Defamation Case Against Atty Hinges On Doctor's Status
• 5 Crisis Lawyering Skills For An Age Of Uncertainty
• Wash. Hospital System Can't Undo $230M Wage Suit Loss
• Dental Co. Tells Chancery Ex-Executive Stole Business
• Texas Accuses Tylenol Makers Of Hiding Autism Danger
• Whistleblower 'Horrified' By Novo Nordisk Drug Sales Tactics
• Bros. Had No Fraud Intent In HIV Drug Scam, Fla. Jury Told
• CFPB Says States Can't Enact Medical Debt Reporting Bans
• CVS Let 401(k) Get Bogged Down With High Fees, Suit Says
• Acadia Pushes For Appeal Of Investors' Partial Early Win
• LifeScan Gets Final OK On Ch. 11 Plan After Deal With PBMs
• Feds Fight Union Bid To Protect Jobs During Gov't Shutdown
• AbbVie Defends Challenge Of Colorado's Discount Drug Law
• Temp Agency Placed Unqualified Nursing Aides, Charges Say
• Colo. Doctor Sues Ex-Employer For Disability Discrimination
• Anticipating FTC's Shift On Unfair Competition Enforcement
• Pa. Hospital Workers Seek Initial Approval For OT Suit Deal
• Judge Tosses Eli Lilly Suit Over Telehealth Weight Loss Drugs
• Biotech Firm MapLight Inks $251M IPO Amid Shutdown
• Ex-Magellan CEO Avoids Prison Over Faulty Lead Tests
• It's Time For The Judiciary To Fix Its Cybersecurity Problem
• Gordon Rees 'Profoundly Embarrassed' By Atty's AI Mistakes
• Calif. Dialysis Bill Violates Free Speech, 9th Circ. Told
• Curaleaf Urges Block On NJ Pot Shop Union Rule
• Pfizer Hit With More Suits Over Depo-Provera
• USAA Defends Medical Reimbursement Cuts In Coverage Row
• 2 Texas Justices Say Qui Tam Constitutionality Needs Review
• 3rd Circ. Revives Nonprofit's Bias Suit Over Permit Denial
• HHS Wound Care Report Highlights Need For Payment Reform
• Mich. Patients, Doctors Fight Pregnancy End-Of-Life Carveout
• LifeScan Urges Court To Force PBMs To Produce Documents
• Hagens Berman Wants Judge DQ, Alleges Drug Lawsuit Bias
• NFL Players' Race Bias Claims Tossed In Concussion Case
• Generic-Drug Makers Want Conn. Price Cap Blocked During Suit
• Eli Lilly Buying Eye Disease Biotech For Up To $262M
• Taxation With Representation: Latham, Wachtell, Gibson Dunn
• Senior Care Exec Says CEO's Estate Must Repay $1.5M Loan
• Paramedics Can't Use Mich. Law To Escape Negligence Suit
• Wash. Justices Skeptical Of Debtor's Collection Notice Stance
• 9th Circ. Calls For Evidence Hearing Over ICE Facility Access
• 6th Circ. Panel Torn On Mich. 'Conversion Therapy' Ban
• NextGen Customers Seek Initial OK Of $19M Data Hack Deal
• RingConn Settles With Oura After ITC Import Ban
• Freshly Launched Legal Org. Plans To Protect Abortion Docs
• Judge Orders State Farm To Restart Paying PIP Claims To Co.
• Genesis Judge Blocks HHS Bid To End Nursing Home Benefits
• SEC Being Misled In CBD Fraud Fight, CEO Claims
• Telehealth Ketamine Provider Hit With Wrongful Death Suit
• Mich. Hospitals Seek To Shake Patient Data-Tracking Suit
• Considering Judicial Treatment Of The 2023 Merger Guidelines
• Eli Lilly Says Pharmacy Mass-Producing Weight Loss Drug
• Geico Avoids Atty Fees In Florida Providers' Suits
• Judge Dings Law Profs In Judge-Shopping Sanctions Case
• McGuireWoods Asks NC Justices To Stay Defamation Case
• Fla. Court Pauses Marijuana Patients' Gun Rights Case
• 5th Circ. Revives Religious Bias Suit Over DOD Vaccine Policy
• Premier Healthcare, Fired Director Settle Age Bias Dispute
• Writing Novels Makes Me A Better Lawyer
• Novo Nordisk Paid Patient Benefits, Not Bribes, Jury Hears
• Ex-Beverly Hills Housewife Boots Defamation Counterclaim
• Monsanto's Roundup Blamed For Husband's Fatal Cancer
• Judge Voids HHS Rule Banning Gender Identity Discrimination
• State AGs Push Back In First Amendment Subpoena Fight
• NIH Sued For Access To Research On Trans Youth Care
• Hi-Tech Pharma Fraud Charges Just A 'Paper Case,' Jury Told
• States Back Boston Hospital In Fight Over Trans Care Records
• COST Urges Ky. Justices To Reject Walgreens' Tax Valuations
• Obstetrician's Win Upheld In 'Outrageous Terminology' Suit
• Purdue Fights Baltimore Objection Ahead Of Ch. 11 Plan Trial
• Unions Pursue More Protection For Federal Workers In Shutdown
• SDNY OpenAI Order Clarifies Preservation Standards For AI
• $18M Yale New Haven Health Data Breach Deal Gets First OK
• 5 Firms Guide $2.1B Alkermes-Avadel Sleep Medicine Deal
• 10th Circ. Won't Revive Ex-IHS Doc's Retaliation Suit
• NC Biz Court Bulletin: COVID Coverage, A Suspect Signature
• DOJ Pushes To Pause DACA Health Suit Due To Shutdown
• Novo Nordisk Says Officials Not Qualified To Doubt Drug Bills
• Anesthesia Giant Cuts Deals To End Hospital Antitrust Cases
• Hemp Co. Alleges Fraud Over $574K Late Kratom Delivery
• 3rd Circ. Reinstates Union Rep's Pharmacy Fraud Charges
• Purdue Touts Wide Support For Latest Ch. 11 Plan
• Third Tribe Signs Deal To Open Cannabis Shops In Minnesota
• Full Fed. Circ. Won't Rehear $125M Medtronic Patent Verdict
• 4 Strategies To Ensure Courts Calculate Restitution Correctly
• Calif. Court Backs Birth Battery Claim, Split On Gender Abuse
• Supreme Court Medina Ruling Erodes Public Health Networks
• PE Giants Ink $18.3B Deal For Hologic Amid Megadeal Blitz
• Food Co. Strikes $4.7M Deal To End ERISA Tobacco Fee Suit
• USCIS Guidance Gives Scope Of New $100K H-1B Fee
• Novo Nordisk Trial Kicks Off Over Kickback Allegations
• NJ Asks If Experts Are Needed For Mental Defenses
• Drugmakers Say Conn. Law Illegally Extends Beyond State
• Colo. High Court Upholds $40M Award In Med Mal Cap Suit
• Ex-Cano Health CEO Settles $70M Suit Over Failed Dental Deal
• Sterigenics Nears Win In Georgia Ethylene Oxide Litigation
• Tylenol Maker Tells FDA Not To Add Autism Warning
• 'A Total Mess': Judge Slams Calif. Privacy Law's Ambiguity
• Assessing The Future Of The HIPAA Reproductive Health Rule
• Lab Cos. Seek $542M For COVID Testing Reimbursement
• 21 AGs Back Planned Parenthood In Funding Freeze Fight
• More Fed. Workers Added To TRO Blocking Shutdown Layoffs
• Catching Up With Delaware's Chancery Court
• Justices Won't Review Repeat Indictment For Medicare Fraud
• Top Court Won't Hear Chicago Hospital's Medicaid Dispute
• High Court Won't Hear Hospital Vax Mandate Case
• Justices Won't Review Merck's Immunity From Vaccine Claims
• Nursing Exec Denied New Trial On Wage-Fixing Claims
• Injury Law Roundup: Uber Wins Bellwether Sex Assault Trial
• Mixed Discretionary Denial Batch Caps Off Big Week For PTAB
• Insys Ex-CEO Babich Agrees To $30M Trustee Deal In Del.
• Texas Appeals Court Revives Yelp Abortion Notice Suit
• Atty Quits Ga. Bar's 'Facade' Committee On Client Solicitation
• CVS Can't Dodge Tobacco Surcharge Suit, Employee Says
• Acadia Investors Score Partial Win In Fraud Class Action
• NJ Parents Keep Fighting State Over Storage Of Babies' DNA
• 3rd Circ. Says No Duty To Inform Criminal Clients Of Liability
• NM Medical Cannabis Co. Tells Tax Court 280E Does Not Apply
• Plasma Co. Worker Exams Shirk Genetic Privacy, Suit Says
• Idaho Asks Justices To Reject Mootness In Trans Ban Case
• Expert Reports Can't Replace Facts In Securities Fraud Cases
• Federal Courts To Scale Back Operations Amid Shutdown
• Latham To Bring On 3 Restructuring Pros From Ropes & Gray
• Boston Scientific Buying Rest Of Pain Therapy Biz For $533M
• NC Justices Say Doctor Can't Appeal Dismissal Denial
• Feds Say Housing Activist Used Homeless For Medicaid Fraud
• DaVita, Fresenius Seek Dismissal Of Dialysis Price-Fix Suit
• Fired K-9 Officer Drops Bias Suit Against Mich. Hospital
• High Court, Not A Single Justice, Should Decide On Recusal
• Trump Unveils IVF Drug Pricing Deal: 'We Want More Babies'
• Calif. Hospitals Sue Over New Healthcare Cost Increase Caps
• US Chamber Sues To Block Trump's $100,000 H-1B Visa Fee
• Texas Panel Blocks Hospital Subpoenas In Trans Care Suit
• Generics Makers Urge 3rd Circ. To Nix Price-Fixing Classes
• 6 Firms To Lead Aflac Data Breach Suit In Georgia
• Fla. Hospital Seeks To Slash $70M Verdict, Cites Medicaid Cap
• Bankrupt Rite Aid Trust Sues Walgreens Over Opioid Costs
• 3 Firms Seek Lead Roles In Conn. Medical Data Breach Suit
• Bavarian Nordic Gets Sweetened $3.1B Bid But Hurdles Linger
• Traveling Solo Makes Me A Better Lawyer
• Fla. Medical Clinic Settles Patient Data Breach Row For $10M
• Texas Appeals Court Pushes Cigna On Payments To Hospitals
• Judge Won't Block Mich. Medicaid Mental Health Restructure
• Ga. Justices Revive Suit Over L'Oréal Hair Relaxer Health Risks
• Colo. Pediatric Provider Sued Over Data Breach
• Chancery 'Rewrote' $3.4B Merger Deal, J&J Tells Del. Justices
• Consumer Says Nail Fungus Product Falsely Marketed
• Conn. Hospital Had Cause To Fire Lawmaker, Judge Confirms
• Bankruptcy Can't End Caterpillar Privacy Suit, Ex-Worker Says
• Judge Denies Class Cert. In Coast Guard Vax Suit
• DOJ's Tracing Rule For Pandemic Loan Fraud Is Untenable
• New Health AI Guidance Features A Provider-Centric Approach
• Cherokee Nation Member Appointed IHS Chief Of Staff
• Feds Seek To Block Pot Legalization Talk In Maine Drug Trial
• Atty Fights Walgreens Sanction Bid In Georgia Bias Suit
• Crowell & Moring Adds Seasoned Healthcare Trial Atty
• Some Federal Workers Win Quick Block On Shutdown Layoffs
• Law School's Missed Lessons: Client Service
• Town Hall Ventures Secures $440M To Invest In AI, Healthcare
• Providers Bring No Surprises Act Fight To High Court
• NC Court Denies Early Ruling In Hospital Antitrust Case
• Full 3rd Circ. Won't Rethink $45M CareDx False Ad Case
• Relief Concerns Grow As Sectoral Tariff Actions Build
• Embryo Loss Class Claims Hinge On Calif. Suit, Judge Says
• 6th Circ. Won't Revive Allergy Tester's Antitrust Case
• How Occasional Activists Have Reshaped Proxy Fights
• Texans Say Drinking Water Tainted With PFAS From Military Base
• Meet HHS General Counsel Michael Stuart
• Humana's 2025 Medicare Ratings Sound, Judge Says
• Aetna Dodges Colo. County's $1.1M Suit Over Unpaid Rebates
• Bid Protest Spotlight: Documentation, Overrides, Eligibility
• Shutdown Imperils Telehealth Access For Medicare Patients
• Freshfields Guides J&J's Planned Orthopedics Unit Spinoff
• Colo. Biz Accuses VA Of Ignoring Veteran-Owned Suppliers
• Ōura Valuation Soars To $11B After $900M Financing Round
• Justices Seek SG Input In 'Lightning Rod' Health Ministry Case
• Judges Back Ga. County's Use Of Outside Attys In Opioid Suit
• Mass. Ruling May Pave New Avenue To Target Subpoenas
• Catching Up With Delaware's Chancery Court
• Covington, Sidley Guide $700M BioCryst Allergic Disease Deal
• High Court Won't Hear FDA Stem Cell Regulation Fight
• Ex-Temple Worker Can Sue Under ADA, Not As Whistleblower
• Federal Worker Unions Press For Immediate Block Of Layoffs
• DOJ Can't Pause Review Of UnitedHealth Deal Amid Shutdown
• AstraZeneca Strikes 'Most Favored Nation' Price Deal
• 'LinkedIn For Doctors' Accused In Chancery Of Inflating Data
• Infosys' Counterclaims Against Competitor Tossed For Now
• Experts Doubt Gold Card Will Siphon Off EB-5 Investors
• Colorado Business Owner Gets Prison For $1.5M Tax Fraud
• Curaleaf Says NJ's Pot Shop Union Requirement Bucks NLRA
• What To Expect After FDA Warnings To GLP-1 Compounders
• Ex-Casino CEO's ERISA Fight Against ND Tribe Gets Trimmed
• Seyfarth Eyes Middle-Market Bounce As Megadeals Dominate
• Covington, Goodwin Guide Bristol Myers' $1.5B Orbital Buy
• Pharma Co. Escapes Suit Over Ex-CEO's Alleged Misconduct
• Ga. Medical Billing Practice Faces Data Breach Class Action
• Why Justices Seem Inclined To Curtail Del. Affidavit Statute
• Prospect Medical Gets OK For $45M Yale Health Deal In Ch. 11
• How Financial Cos. Can Prep As NYDFS Cyber Changes Loom
• Therapist Backs Out Of Plea In Patient Fund Fraud Case
• Taxation With Representation: Sullivan, MoFo, Freshfields
• UK Litigation Roundup: Here's What You Missed In London
• Rite Aid Fires Back At Claims It Broke CVS Sale Deal
• Adapting To Private Practice: 3 Tips On Finding The Right Job
• Biotronik Wants Full 9th Circ. Review Of Whistleblower Ruling
• Pharma Co. Looks To Nix 'Absurd' Award Over Acne Drug
• 9th Circ. Probes Buyers On HIV Drug Antitrust Claims
• McKesson Aims To Escape Dealer Claims In Overdose Death
• Fed. Circ. Affirms Contractor Is Due Money For COVID Delays
• Aetna Inks ERISA Deal Over Nixed Spinal Surgery Claims
• ADA Doesn't Stop At Prison Gates, 3rd Circ. Says In Reversal
• San Antonio Abandons Out-Of-State Abortion Travel Appeal
• Hemp Co. Asks Del. Court To Defer Ex-Exec's Suit To Australia
• Tort Report: Nuked 'Nuclear Verdict' Stays, Texas Justices Say
• Tivity Health Investors Seek Final OK Of $17M Settlement
• How Courts May Interpret Data-Driven Healthcare Fraud Suits
• AG Watch: Va. Race Spotlights Consumer Protection Priorities
• Ropes, Kirkland Guide $5.2B Novo Nordisk Liver Disease Deal
• Va. Panel Nixes $2.5M Med Mal Verdict Over Jury Instruction
• Painting Makes Me A Better Lawyer
• NYC Takes Social Media Youth Addiction Suit To Federal Court
• Chancery Extends Pause On Hospital Board Law Challenge
• ALN Medical Strikes $4M Data Breach Deal With 1.8M Users
• Ex-Hospital CEO Drops Fraud Suit Against Former Employer
• GSK Doesn't Have To Explain COVID Vax Claims For Moderna
• Del. Judge May Have Mallinckrodt Choose: Injunction Or $10M
• Army Finds Support At Fed. Circ. In Fight Over COVID Delays
• $20M Deal Over Wash. Hospital Wage Claims Gets Final OK
• Arnall Golden Sanctioned For Giving Feds ERISA Suit Docs
• Jackson Walker Gets Healthcare Atty From Sheppard Mullin
• Trump Admin Challenges Denial Of Trans Care Subpoena
• Minn. 'Sober Home' Companies Sued After Tenant Killed 2
• Atty Fee Concerns Sink Health Provider's $2M Privacy Deal
• Aetna COVID-19 Test Provider Sues Insurer For 'Unpaid' $53M
• Fed. Circ. Focuses On Breadth Of UPenn IP In Eligibility Fight
• Urologist Provider Must Face Data Leak Claims, Panel Says
• 9th Circ. Revives Ex-Service Members' Antimalarial Drug Suit
• NJ Surgeon On The Hook For Full $1.6M In Med Mal Case
• 4th Circ. Urged To Reverse $10M Medicare Fraud Conviction
• Prospect Medical Fights $1M Software Fee Claims In Ch. 11
• Drug Tax Outdoes Biblical Punishment, 5th Circ. Judge Says
• 9th Circ. Rejects 'Kitchen Sink' Challenge To Vaccine Mandate
• Northwestern Wants ERISA Health Offering Suit Tossed
• Amazon Supplement Buyers Seek Spoliation Penalties
• AGs Rip DOJ Bid To Pause Planned Parenthood Funding Suit
• EMS Workers Tell 4th Circ. NC County Owes Them Wages
• Justices Probe Standard Of Care In 'Conversion Therapy' Case
• Premera Defends IBS Drug Antitrust Claims Against Takeda
• 2nd Circ. Rules Inmates Not Entitled To Specific Gender Care
• Approach The Bench: Judge Kaplan On Suit Against The Gov't
• EMTs Appeal Losses Ahead Of False Death Declaration Trial
• La. Challenges Mail-Order Access To Abortion Medication
• Global Wound Care Flags Medicare Delay Amid Shutdown
• Rutgers Must Rehire Union-Repped Psych Prof, Court Says
• 3 Firms Advise On Qualtrics' $6.75B Press Ganey Forsta Buy
• Hybrid Claims In Antitrust Disputes Spark Coverage Battles
• New H-2A Wage Rule May Worsen Farm Labor Shortages
• Justices Pressed To Overturn TM Denial Of Dark Green Gloves
• Judge Certifies Class In United Behavioral Health Billing Suit
• Justices Hint At Barring Del. Med Mal Law In Federal Court
• Conn. Judges Unsure Why Court Called IVF A Sexual Act
• Drug Ad Crackdown Demonstrates Admin's Aggressive Stance
• Pa. Hospitals Ink $28.5M Deal In No-Poach Deal Antitrust Fight
• 2 Firms To Lead Humana Investor Suit Over Post-COVID Costs
• High Court Won't Take Up Md. Retirees' Drug Benefits Suit
• Bernstein, Robbins Geller Vie For Top Co-Counsel In Deal Row
• 3rd Circ. Rejects Novo Nordisk's Medicare Pricing Challenge
• Hagens Berman Fights Sanctions Over Thalidomide Suits
• Protecting Sensitive Court Filings After Recent Cyber Breach
• Health Data Co. Accused Of Post-Deal Doc Deletions
• Justices Won't Review 5th Circ. Ending ACA Trans Policy Suit
• Mass. Justices Say Harvard Must Face Cadaver Theft Claims
• Justices Skip Fight Over NJ Healthcare Worker Vax Mandate
• Justices Won't Weigh If Home Care Travel Time Compensable
• Justices Skip TM Dispute Over Pink Color In Hip Implants
• Up First At High Court: Election Laws & Conversion Therapy
• 4 Top Supreme Court Cases To Watch This Term
• Fed. Challenge To Ala. Pot Regulators Must Wait For State Suit
• Fla. Jury Hears Law Weakened DEA Efforts In Opioid Crisis
• 6th Circ. Will Hear Ohio PBM Fight Arguments In December
• Vape Cos. Tell 5th Circ. FDA Erred On Flavored E-Cigs
• NIH Sets Patent License Policy Aimed At Promoting Access
• Osborne Clarke France Hires Arbitration Practice Head
• 11th Circ. Pushes Forward Fla.'s ACA Trans Health Appeal
• Nurse Staffing Exec Says Jury Misled In Wage-Fixing Case
• Cigna Inks $5.7M Ghost Network Suit Settlement
• Native Groups Urge Action As Shutdown Threatens Services
• Trump Admin Hit With Suit Over $100K H-1B Fees
• The Roberts Court At 20: How The Chief Is Reshaping America
• Temple U., Cancer Center Beat Professor's Sex Bias Suit
• Ga. Insurer Can't Skirt Suit Over NC Captive Insurer's Collapse
• FDA OKs New Generic Abortion Pill, Drawing Conservative Ire
• Wrongful-Death Damages Cap Case Remanded To Trial Court
• Veteran Services Co. Must Face Chancery Self-Dealing Claims
• NC Court Rejects McGuireWoods' Immunity In Defamation Suit
• Feds Eye Partial Pretrial Ruling In Regeneron FCA Case
• NC Chief Judge Scolds Medical Supply Co.'s 'Rude' Demand
• Colo. Healthcare Nonprofit Sues Gov. Over Medicaid Cuts
• AstraZeneca Asks Judge To Block Colorado's 340B Drug Law
• Fed. Circ. Affirms Cutting $10M Med Device IP Verdict To $1
• Ill. Panel Backs Whistleblower's $3.5M Retaliation Verdict
• Ill. Panel Rejects Challenge To Abortion Coverage Mandate
• Mass. Court Denies States' Bid To Block ACA Subsidy Cuts
• Healthcare AI Co. Says Biz Partner Holding IP 'Hostage'
• Many Cos. Not Ready For National Security Risks, Report Says
• Justices To Hear Clash Over State Med Mal Laws In Fed. Court
• Ex-Firm Can't Revive Malicious Prosecution Suit In 11th Circ.
• How Gov't Shutdown Will Affect Federal Health Agencies
• Singaporean Biotech To Go Public Via $1.5B SPAC Merger
• Agency Ex-Exec Says He Was Misled About CEO Agreement
• UChicago Medicine Ducks Class Claims In Patient Privacy Suit
• Cravath, Kirkland Lead Berkshire's $9.7B OxyChem Buy
• Judging Figure Skating Makes Me A Better Lawyer
• Pa. Court Affirms 53-Year Sentence In Baby's Drug Death
• Eli Lilly's Drug Suit Slammed As 'Anti-Competitive' Move
• Ga. Panel Revives Injury Suit Alleging IV Mixup Against Emory
• Medtronic Knocks Out Investor Suit Over Insulin Pump Issues
• DHS Accused Of Illegal Data Use In Voter Purge Lawsuit
• Texas Judge Sends Mifepristone Challenge To Missouri Court
• Trans Athlete Fights To Halt High Court Review Of Idaho Ban
• $100K H-1B Fee May Disrupt Rural Healthcare Needs
• 3rd Circ. Hints Forum Query Premature In $139M Award Row
• Ga. Atty DQ'd From 'Extremely Weird' Pharma Fraud Case
• What Ethics Rules Say On Atty Discipline For Online Speech
• Cozen O'Connor Adds Healthcare Litigator To Philly Office
• Weil, Morgan Lewis Steer Up To $900M Biopharma Purchase
• Ga. Panel Backs Doctors In Brothers' Suit Over Mom's Death